Market research
VTL Vital Therapies, Inc
NASDAQ USD Other
Latest close
As of 05 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- 0.5
- Dividend yield
- 0.0%
- Beta
- Not available
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Other
- Industry
- Other
- ISIN
- Not available
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- 0.5
- Dividend yield
- 0.0%
- Beta
- Not available
- MarketCapitalization
- Not available
About
About Vital Therapies, Inc
Vital Therapies, Inc., a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is based in San Diego, California.
Research context
Vital Therapies, Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Other
- Industry
- Other
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the VTL discussion.
No comments yet
Start a focused discussion about VTL.